[go: up one dir, main page]

CY1109327T1 - Μια μεθοδος για την παρασκευη εναντιομερικα καθαρης μιρταζαπινης - Google Patents

Μια μεθοδος για την παρασκευη εναντιομερικα καθαρης μιρταζαπινης

Info

Publication number
CY1109327T1
CY1109327T1 CY20091100894T CY091100894T CY1109327T1 CY 1109327 T1 CY1109327 T1 CY 1109327T1 CY 20091100894 T CY20091100894 T CY 20091100894T CY 091100894 T CY091100894 T CY 091100894T CY 1109327 T1 CY1109327 T1 CY 1109327T1
Authority
CY
Cyprus
Prior art keywords
preparing
antiometrically
mirtazapin
pure
acid
Prior art date
Application number
CY20091100894T
Other languages
Greek (el)
English (en)
Inventor
Johannes Hubertus Wieringa
De Ven Adrianus Antonius Martinus Van
Gerardus Johannes Kemperman
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of CY1109327T1 publication Critical patent/CY1109327T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CY20091100894T 2003-07-10 2009-08-25 Μια μεθοδος για την παρασκευη εναντιομερικα καθαρης μιρταζαπινης CY1109327T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03102095 2003-07-10
EP04741958A EP1656365B1 (fr) 2003-07-10 2004-07-05 Procede pour la preparation de mirtazapine enantiomeriquement pur

Publications (1)

Publication Number Publication Date
CY1109327T1 true CY1109327T1 (el) 2014-07-02

Family

ID=34042934

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100894T CY1109327T1 (el) 2003-07-10 2009-08-25 Μια μεθοδος για την παρασκευη εναντιομερικα καθαρης μιρταζαπινης

Country Status (35)

Country Link
US (2) US8058436B2 (fr)
EP (1) EP1656365B1 (fr)
JP (1) JP4668184B2 (fr)
KR (1) KR20060056315A (fr)
CN (1) CN100558722C (fr)
AR (1) AR046494A1 (fr)
AT (1) ATE433965T1 (fr)
AU (1) AU2004255874B2 (fr)
BR (1) BRPI0412447A (fr)
CA (1) CA2531165C (fr)
CO (1) CO5640123A2 (fr)
CY (1) CY1109327T1 (fr)
DE (1) DE602004021605D1 (fr)
DK (1) DK1656365T3 (fr)
EC (1) ECSP066271A (fr)
ES (1) ES2327123T3 (fr)
HR (1) HRP20051019A2 (fr)
IL (1) IL172549A0 (fr)
IS (1) IS2674B (fr)
LT (1) LT5382B (fr)
LV (1) LV13441B (fr)
MX (1) MXPA06000325A (fr)
NO (1) NO20056175L (fr)
NZ (1) NZ544360A (fr)
PE (1) PE20050323A1 (fr)
PL (1) PL1656365T3 (fr)
PT (1) PT1656365E (fr)
RS (1) RS20050972A (fr)
RU (1) RU2352566C2 (fr)
SG (1) SG144914A1 (fr)
SI (1) SI1656365T1 (fr)
TW (1) TWI335915B (fr)
UA (1) UA83666C2 (fr)
WO (1) WO2005005410A1 (fr)
ZA (1) ZA200600019B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5080050B2 (ja) * 2005-09-26 2012-11-21 住友化学株式会社 光学活性なピペラジン化合物の製造方法
CN102126982A (zh) * 2005-09-26 2011-07-20 住友化学株式会社 光学活性的哌嗪化合物的制造方法
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
TW200815370A (en) * 2006-06-16 2008-04-01 Organon Nv Stereoselective synthesis of (S)-1-methyl-3-phenylpiperazine
EP2119709A4 (fr) * 2007-02-09 2011-08-17 Kaneka Corp Procédé de fabrication d'un dérivé de 2-arylpiperazine optiquement actif
JP5192707B2 (ja) 2007-03-22 2013-05-08 住友化学株式会社 ミルタザピンの製造方法
MX2009010967A (es) * 2007-04-11 2009-12-15 Organon Nv Un metodo para la preparacion de mirtazapina.
US7994314B2 (en) 2007-04-11 2011-08-09 N.V. Organon Method for the preparation of an enantiomerically pure benzazepine
KR101485418B1 (ko) * 2013-05-29 2015-01-26 주식회사 메디켐코리아 고순도 미르타자핀의 제조방법
US10603272B2 (en) 2015-02-27 2020-03-31 Kindred Biosciences, Inc. Stimulation of appetite and treatment of anorexia in dogs and cats
KR102540021B1 (ko) * 2020-12-02 2023-06-07 (주)유케이케미팜 대량 생산에 적합한 미르타자핀의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959470A (en) * 1972-11-28 1976-05-25 Mikhail Davidovich Mashkovsky Psychotropic medicinal preparation
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
TW206227B (fr) * 1989-10-05 1993-05-21 Sankyo Co
ATE289816T1 (de) 1997-11-14 2005-03-15 Akzo Nobel Nv Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
JPH11222407A (ja) * 1997-11-14 1999-08-17 Sankyo Co Ltd 新規殺菌剤
YU74101A (sh) * 1999-04-19 2004-09-03 Teva Pharmaceutical Industries Ltd. Nova sinteza i kristalizacija jedinjenja koja sadrže prsten piperazina
US20030069417A1 (en) * 1999-04-19 2003-04-10 Claude Singer Novel synthesis and crystallization of piperazine ring-containing compounds
US6068695A (en) * 1999-07-13 2000-05-30 Bayer Corporation Process for the continuous preparation of quinacridones
WO2001025185A1 (fr) 1999-09-30 2001-04-12 Sumika Fine Chemicals Co., Ltd. Procede de production de derive de piperazine
AU6474200A (en) * 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
KR20020069371A (ko) 2000-02-11 2002-08-30 악조 노벨 엔.브이. 수면 장애의 치료를 위한 미르타자핀의 용도
JP2001342188A (ja) * 2000-03-27 2001-12-11 Takeda Chem Ind Ltd 縮合ピラゾール誘導体、その製造法および用途
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts

Also Published As

Publication number Publication date
SI1656365T1 (sl) 2009-10-31
TW200510426A (en) 2005-03-16
PT1656365E (pt) 2009-09-01
CN100558722C (zh) 2009-11-11
MXPA06000325A (es) 2006-03-30
BRPI0412447A (pt) 2006-09-19
LT5382B (lt) 2006-11-27
IL172549A0 (en) 2006-04-10
RU2006103992A (ru) 2006-06-27
IS8184A (is) 2005-12-15
TWI335915B (en) 2011-01-11
PE20050323A1 (es) 2005-05-16
UA83666C2 (ru) 2008-08-11
EP1656365A1 (fr) 2006-05-17
RU2352566C2 (ru) 2009-04-20
PL1656365T3 (pl) 2009-10-30
RS20050972A (sr) 2008-06-05
LT2005107A (en) 2006-06-27
CN1820000A (zh) 2006-08-16
AU2004255874A1 (en) 2005-01-20
HRP20051019A2 (en) 2006-02-28
KR20060056315A (ko) 2006-05-24
SG144914A1 (en) 2008-08-28
CA2531165A1 (fr) 2005-01-20
AR046494A1 (es) 2005-12-14
JP2009513537A (ja) 2009-04-02
HK1086841A1 (en) 2006-09-29
NO20056175L (no) 2006-01-23
US20060229300A1 (en) 2006-10-12
US20100179319A1 (en) 2010-07-15
LV13441B (en) 2006-08-20
US8058436B2 (en) 2011-11-15
NZ544360A (en) 2008-05-30
CO5640123A2 (es) 2006-05-31
ECSP066271A (es) 2006-07-28
DE602004021605D1 (de) 2009-07-30
AU2004255874B2 (en) 2010-10-28
JP4668184B2 (ja) 2011-04-13
WO2005005410A1 (fr) 2005-01-20
ES2327123T3 (es) 2009-10-26
IS2674B (is) 2010-09-15
ZA200600019B (en) 2007-01-31
ATE433965T1 (de) 2009-07-15
CA2531165C (fr) 2011-08-30
EP1656365B1 (fr) 2009-06-17
DK1656365T3 (da) 2009-09-14

Similar Documents

Publication Publication Date Title
CY1109327T1 (el) Μια μεθοδος για την παρασκευη εναντιομερικα καθαρης μιρταζαπινης
CY1107596T1 (el) Παραγωγα τετραϋδροναφθαλινιου, μεθοδος για την παραγωγη αυτων και η χρηση τους ως αντιφλεγμονωδη
CY1106246T1 (el) Ενωσεις δις(θειο-υδραζιδιο αμιδιου) για θepαπεια καρκινου διασταυρουμενης αντοχης
GT200300296A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
CY1108398T1 (el) Διαδικασια και ενδιαμεσα για την παραγωγη 7-υποκατεστημενων αντιοιστρογονων
CY1112754T1 (el) Μεθοδοι και ενδιαμεσα για την παρασκευη παραγωγων ν4-φαινυλ-κιναζολιν-4-αμινης
CY1108041T1 (el) Αναστολεις της rho-κινασης
ATE417051T1 (de) Polymorphe von clopidogrel-hydrogensulfat
CY1108183T1 (el) Θειαζολυλο-διυδρο-ινδαζολια
ATE525067T1 (de) Amino-substituierte (e)-2,6-dialkoxystyryl 4- substituierte benzylsulfone zur behandlung von proliferierenden erkrankungen
CY1109300T1 (el) Νεοι συντηγμενοι ετεροκυκλικοι δακτυλιοι και χρησεις αυτων
CY1111428T1 (el) Μεθοδος για τη συνθεση της 5-(μεθυλ-1η-ιμιδαζολ-1-υλο)-3-(τριφθορομεθυλο)-βενζολαμινης
CO5601045A2 (es) Procedimiento para la fabricacion de compuestos organicos
DE60133817D1 (de) Verfahren zur herstellung von aplidin und neue antitumoralen derivate, verfahren zu deren herstellung und zu deren verwendung
DE60209537D1 (de) Neue kristalline formen von meloxicam, deren herstellung und verfahren zu deren umwandlung ineinander
ATE330963T1 (de) Amorphe feste modifikation von bis(2,4- dicumylphenyl) pentaerythritdiphosphit
ECSP045396A (es) Proceso para preparar derivados de 6-alquiliden penem
ATE516031T1 (de) Verbindungen gegen krebs
CY1106759T1 (el) Θεραπεια της δυσκινησιας
CU24719B1 (es) Derivados de hidroquinona disustituidos en 2,5 o 2,6 con un grupo carboxi, sulfo o amido útiles como medicamentos
GB0512099D0 (en) Compounds
ATE391113T1 (de) Verfahren zur herstellung von pentafluorethan
EA200400876A1 (ru) Способ получения производных толуола
ATE301127T1 (de) Ferrocenylliganden und ein verfahren zur herstellung solcher liganden
CY1109434T1 (el) Νεα διαδικασια και ενδιαμεσα παρασκευης ενωσεων 19-nor-στερο-des-17-αλογονων